Inspire Investing LLC Takes Position in Pediatrix Medical Group, Inc. $MD

Key Points

• Inspire Investing LLC acquired a new stake in Pediatrix Medical Group during the 2nd quarter, purchasing 64,120 shares valued at approximately $920,000.
• Several large investors significantly increased their holdings in Pediatrix Medical Group during the 1st quarter, contributing to institutional investors owning 97.71% of the company.
• Pediatrix Medical Group outperformed earnings expectations with reported earnings of $0.53 per share, exceeding analyst estimates of $0.42, despite a 7.1% drop in revenue compared to the previous year.

Inspire Investing LLC bought a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 64,120 shares of the company's stock, valued at approximately $920,000. Inspire Investing LLC owned about 0.07% of Pediatrix Medical Group as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently modified their holdings of MD. GAMMA Investing LLC increased its position in shares of Pediatrix Medical Group by 4,530.0% during the 1st quarter. GAMMA Investing LLC now owns 37,225 shares of the company's stock valued at $539,000 after purchasing an additional 36,421 shares during the last quarter. SG Americas Securities LLC increased its position in shares of Pediatrix Medical Group by 194.0% during the 1st quarter. SG Americas Securities LLC now owns 38,405 shares of the company's stock valued at $556,000 after purchasing an additional 25,343 shares during the last quarter. Ritholtz Wealth Management increased its position in shares of Pediatrix Medical Group by 73.7% during the 1st quarter. Ritholtz Wealth Management now owns 24,119 shares of the company's stock valued at $349,000 after purchasing an additional 10,236 shares during the last quarter. Diversified Trust Co bought a new position in shares of Pediatrix Medical Group during the 1st quarter valued at approximately $236,000. Finally, New York State Teachers Retirement System increased its position in shares of Pediatrix Medical Group by 1.9% during the 1st quarter. New York State Teachers Retirement System now owns 133,313 shares of the company's stock valued at $1,932,000 after purchasing an additional 2,527 shares during the last quarter. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Price Performance

MD opened at $15.80 on Friday. Pediatrix Medical Group, Inc. has a 12-month low of $11.84 and a 12-month high of $18.22. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The business's fifty day simple moving average is $16.27 and its 200-day simple moving average is $14.49. The company has a market capitalization of $1.38 billion, a price-to-earnings ratio of 12.25 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The business had revenue of $468.84 million for the quarter, compared to the consensus estimate of $464.37 million. During the same quarter in the prior year, the company earned $0.34 EPS. The business's revenue was down 7.1% compared to the same quarter last year. On average, equities research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on MD. Leerink Partners boosted their price objective on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a "market perform" rating in a report on Friday, September 5th. Wall Street Zen upgraded Pediatrix Medical Group from a "buy" rating to a "strong-buy" rating in a report on Saturday, October 4th. Zacks Research cut Pediatrix Medical Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday, October 7th. UBS Group boosted their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a report on Thursday, August 14th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Pediatrix Medical Group in a report on Wednesday. Two equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $16.79.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.